Kythera Biopharma(美国)

Kythera Biopharmaceuticals

美国,KytheraBiopharma,www.kytherabiopharma.comKYTHERABiopharmaceuticals主要是将doublechinswithBayer的注射疗法进行商业化KYTHERAisaclinical-stagebiopharmaceuticalcompanyfocusedonthediscovery,developmentandcommercializa tionofnovelprescriptionproductsfortheaestheticmedicinemarket.TheaestheticsmarkethasgrowndramaticallyintheUnitedStates,drivenbyalargepopulationofconsumerslookingtominimizeanddelaysignsofagingandimprovetheirgeneralappearance.Leadingthegrowthinthenon-surgicalaestheticsmarketarefacialinjectableproducts,principallybotulinumtoxinsanddermalfillers,whichhavesolidifiedtheirplaceasthefoundationoftheaestheticmedicinemarket.Whilebotulinumtoxinsanddermalfillershavecreatedamarketfornon-surgicalrejuvenationoftheupperandmid-face,however,undesirablesubmentalfat,ordoublechin,remainsanimportantyetunaddressedaesthetictargetforinjectablefacialtreatment.